WP
SNDX icon

Woodline Partners’s Syndax Pharmaceuticals SNDX Stock Holding History

Woodline Partners’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.3M Hold
1,250,760
– – 0.08% 300
2026
Q1 		$29.2M Buy
1,250,760
+92
+0% +$2K 0.11% 253
2025
Q4 		$26.3M Sell
1,250,668
-299,852
-19% -$5.23M 0.1% 259
2025
Q3 		$23.9M Sell
1,550,520
-342,231
-18% -$4.48M 0.11% 244
2025
Q2 		$17.7M Buy
1,892,751
+948
+0.1% +$10.4K 0.09% 313
2025
Q1 		$23.2M Hold
1,891,803
– – 0.15% 199
2024
Q4 		$25M Sell
1,891,803
-4,229
-0.2% -$72.4K 0.17% 175
2024
Q3 		$36.5M Buy
1,896,032
+350,504
+23% +$7.24M 0.31% 101
2024
Q2 		$31.7M Buy
1,545,528
+1,241
+0.1% +$26K 0.3% 100
2024
Q1 		$36.8M Buy
1,544,287
+71
+0% +$1.58K 0.34% 88
2023
Q4 		$33.4M Buy
1,544,216
+1,510,149
+4,433% +$23.2M 0.36% 79
2023
Q3 		$495K Sell
34,067
-578,249
-94% -$10.9M 0.01% 496
2023
Q2 		$12.8M Buy
+612,316
New +$12.7M 0.15% 176
2022
Q4 		– Sell
-789,273
Closed -$19M – 837
2022
Q3 		$19M Buy
+789,273
New +$17.7M 0.27% 110
2022
Q1 		– Sell
-310,377
Closed -$6.79M – 813
2021
Q4 		$6.79M Sell
310,377
-270,931
-47% -$5.01M 0.1% 248
2021
Q3 		$11.1M Buy
581,308
+373,496
+180% +$6.22M 0.18% 148
2021
Q2 		$3.57M Buy
+207,812
New +$3.81M 0.07% 268
2021
Q1 		– Sell
-77,699
Closed -$1.73M – 471
2020
Q4 		$1.73M Buy
+77,699
New +$1.61M 0.05% 200

Other funds holding SNDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Woodline Partners's SNDX Position: Q2 2026 in Review

Woodline Partners held its Syndax Pharmaceuticals (SNDX) position steady in Q2 2026 at 1,250,760 shares worth $27.3M. The position accounts for 0.08% of the portfolio, ranked #300.

Woodline Partners first reported a position in SNDX in Q4 2020 and has held it in 18 quarters since. The position peaked at $36.8M in Q1 2024. 243 funds tracked by Wall St. Rank hold SNDX as of Q2 2026.

  • Woodline Partners held 1,250,760 shares of Syndax Pharmaceuticals worth $27.3M as of Q2 2026.
  • Woodline Partners left its Syndax Pharmaceuticals share count unchanged in Q2 2026.
  • Syndax Pharmaceuticals made up 0.08% of Woodline Partners's portfolio in Q2 2026, its #300 holding.
  • Woodline Partners first reported a position in Syndax Pharmaceuticals in Q4 2020 and has held it in 18 quarters since.
  • Woodline Partners's Syndax Pharmaceuticals position peaked at $36.8M in Q1 2024.
  • 243 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q2 2026.

Based on Woodline Partners's 13F filing for Q2 2026, filed 14 Aug 2026.